Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2005
05/25/2005EP1531793A1 Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
05/25/2005EP1531792A2 Abuse-resistant opioid dosage form
05/25/2005EP1531790A1 Cosmetic composition structured with silicone polymers and film-forming resins
05/25/2005EP1531690A2 Nutraceutic compositions and food supplements containing nadh
05/25/2005EP1531684A1 Method for controlling hairballs
05/25/2005EP1531674A2 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
05/25/2005EP1458732B1 Method for preparing a glucosamine compound, and compound thus obtained
05/25/2005EP1451189B1 4-(1,3,4-thiadiazol-2-yl)-1,4-diazabicyclo- 3.2.2]nonane derivatives, preparation and therapeutic use thereof
05/25/2005EP1442016A4 1h-indole derivatives as a highly selective cyclooxygenase-2 inhibitor
05/25/2005EP1411908B1 Nitrogen oxide generating compositions for the treatment of subungual infections
05/25/2005EP1408944B1 Erucamide compounds for the treatment and prevention of disturbances of the secretory system
05/25/2005EP1372670B1 Caloporoside derivatives, methods for the production thereof and their use
05/25/2005EP1365762A4 Method for increasing leptin levels using nicotinic acid compounds
05/25/2005EP1363654A4 Fab i and inhibition of apicomplexan parasites
05/25/2005EP1341791B1 Thioether substituted imidazoquinolines
05/25/2005EP1330562B1 Method for the production of low defect density silicon
05/25/2005EP1307594A4 Association of sim2 with cancer
05/25/2005EP1287137B1 REGULATION OF HUMAN $g(a)1A?ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
05/25/2005EP1286673B1 Ligands of integrin receptors
05/25/2005EP1282592B1 Use of amines
05/25/2005EP1261333B1 Use of topiramate for the treatment and diagnosis of sleep disordered breathing and means for carrying out the treatment and diagnosis
05/25/2005EP1259231B1 Naphthoquinone derivatives as cd45 inhibitors
05/25/2005EP1214059B1 Surface modified particulate compositions of biologically active substances
05/25/2005EP1165106B1 Composition and method for inducing apoptosis in prostate cancer cells by m-dna and mcc
05/25/2005EP1165081B1 Process for preparing tolperison-containing pharmaceutical preparations for oral administration
05/25/2005EP1165058B1 Azalide antibiotics for the topical treatment or prevention of ocular infections
05/25/2005EP1163335B1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
05/25/2005EP1162973B1 Cilostazol preparation
05/25/2005EP1161146B1 Deep penetrating antimicrobial compositions
05/25/2005EP1140814B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
05/25/2005EP1100481B1 Pharmaceutical formulations comprising beclomethasone dipropionate for the treatment of inflammatory bowel disease
05/25/2005EP1093371B1 Use of fk506 and related macrolides in the manufacture of a medicament for treatment or prevention of pain
05/25/2005EP1066254B1 C11 oxymyl and hydroxylamino prostaglandins useful as fp agonists
05/25/2005EP1064281B1 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents
05/25/2005EP1056724B1 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands
05/25/2005EP1054993B1 PROCESS FOR THE OBTAINING OF HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY
05/25/2005EP1047701B1 Mitochondrially targeted antioxidants
05/25/2005EP1044023B1 A covalent conjugate of clozapine with a fatty acid and its use for treating schizophrenia
05/25/2005EP1039911B1 MORPHOLINO-N-ETHYL ESTER PRODRUGS OF INDOLE sPLA 2 INHIBITORS
05/25/2005EP1033132B1 Rapidly soluble drug composition comprising micronized as-3201
05/25/2005EP0946511B1 Novel compounds with analgesic effect
05/25/2005EP0907652B1 Immunosuppressive compounds and methods
05/25/2005EP0904274B1 Farnesyl transferase inhibitors
05/25/2005EP0888541B1 Cryptic peptides and method for their identification
05/25/2005EP0880362B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b 4 receptor antagonist
05/25/2005EP0862461B1 Methods of treating established colitis using antibodies against il-12
05/25/2005EP0836613B1 Water-soluble adenosine kinase inhibitors
05/25/2005EP0814796B1 Use of a r-nsaid in a protective composition for the treatment of colorectal cancer
05/25/2005EP0813416B1 Reduction of infarct volume using citicoline
05/25/2005EP0755451B1 Materials and methods for management of hyperacute rejection in human xenotransplantation
05/25/2005DE202005004183U1 Formulation for analgesic ear drops contains polyhydric alcohol, especially butan-1,3-diol or glycerol, dimethyl sulfoxide and optionally acid or buffer system and dexpanthenol
05/25/2005DE10359336A1 Use of potassium channel openers in synergistic combination with sodium channel inhibiting/influencing active compounds for treating pains accompanied by increase in muscle tone
05/25/2005DE10359335A1 Kombinationen aus Kaliumkanalöffnern und Natriumkanalinhibitoren oder Natriumkanal beeinflussenden Wirkstoffen zur Behandlung von Schmerzzuständen Combinations of potassium channel openers and sodium channel inhibitors and sodium channel influencing agents for the treatment of pain
05/25/2005DE10351035A1 Pharmazeutische Licofelone-Formulierung Pharmaceutical formulation licofelone
05/25/2005DE10350409A1 Method employing chinolones and related substances for treatment and prophylaxis of genetic diseases causing local mutations and comparable defects in higher organisms, including human beings
05/25/2005DE10348022A1 Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
05/25/2005DE10164844B4 Tocopherol-Konzentrat Tocopherol concentrate
05/25/2005CN1620499A Igamete recruitment and developmental competence in mammals by inhibiting the de novo sterol biosynthesis and/or promoting sterol efflux
05/25/2005CN1620468A Novel anti-igf-ir antibodies and uses thereof
05/25/2005CN1620467A Secreted protein
05/25/2005CN1620463A Pesticidal spinosyn derivatives
05/25/2005CN1620461A 2-amino-propanol derivatives
05/25/2005CN1620460A Crystalline hydrochloride of 7-(((5-amino-1, 2, 4-thiadiazol-3-yl)(fluoromethoxyimino) acetyl) amino) -3- ((imino-1-piperazinylmethyl)methylhydrazono)-methyl-3-cephem-4-carboxylic acid
05/25/2005CN1620459A 稠合双环嘧啶衍生物 Fused bicyclic pyrimidine derivative
05/25/2005CN1620458A 噻吩并嘧啶 Thienopyrimidine
05/25/2005CN1620457A Tetracyclic heterocompounds as estrogen receptor modulators
05/25/2005CN1620455A Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
05/25/2005CN1620454A Amyloid plaque aggregation inhibitors and diagnostic imaging agents
05/25/2005CN1620453A Thiazolidinedione derivative and its use as antidiabetic
05/25/2005CN1620452A 3, 4-dihydro-1h-isoquinoloin-2-yl-derivatives
05/25/2005CN1620451A Benzhydryl derivatives
05/25/2005CN1620448A Piperidine-2, 6-diones heterocyclically substituted in the 3-position
05/25/2005CN1620447A Isochroman compounds for treatment of cns disorders
05/25/2005CN1620446A Retinol derivatives and cosmestics composition containing the same
05/25/2005CN1620440A Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
05/25/2005CN1620439A Pancreatic lipase inhibitor compounds, their synthesis and use
05/25/2005CN1620438A 5, 6-diaryl-pyrazine-2-amide derivatives as CBI antagonists
05/25/2005CN1620435A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
05/25/2005CN1620434A Pyrrolidine-2-ones as factor Xa inhibitors
05/25/2005CN1620433A Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme
05/25/2005CN1620431A (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
05/25/2005CN1620430A 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of PPAR-alpha
05/25/2005CN1620429A Derivatives of alpha-phenylthiocarboxylic and g(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to PPAR alpha activation
05/25/2005CN1620424A Compounds for the treatment of inflammatory disorders
05/25/2005CN1620423A Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (PPAR)
05/25/2005CN1620422A Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (PPAR)
05/25/2005CN1620421A Substituted alkyl diamine
05/25/2005CN1620420A Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
05/25/2005CN1620419A 1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists
05/25/2005CN1620414A 维生素d类似物 Vitamin d analogues
05/25/2005CN1620413A Method for stabilizing reduced coenzyme Q 10 and composition therefor
05/25/2005CN1620333A Apparatus and process for preparing crystalline particles
05/25/2005CN1620325A Superoxide dismutase mimics for the treatment of ocular disorders and diseases
05/25/2005CN1620314A Gas micro-liposome compound
05/25/2005CN1620312A Remedies for chronic kidney diseases
05/25/2005CN1620309A Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
05/25/2005CN1620305A Method of inducing apoptosis and compositions therefor
05/25/2005CN1620304A Prevention and treatment of oxidative stress disorders by glutathione and phase IIdetoxification enzymes
05/25/2005CN1620302A Pharmaceutical compositions comprising one or more steroids one or more tetrahydrofolate components and vitamin b12
05/25/2005CN1620301A Pharmaceutically acceptable phosphate-glycerol carrying bodies
1 ... 4680 4681 4682 4683 4684 4685 4686 4687 4688 4689 4690 4691 4692 4693 4694 4695 4696 4697 4698 4699 4700 ... 7860